540 related articles for article (PubMed ID: 31931831)
21. Very Low Frequency of Drug Therapy of Alcohol Dependence in Germany - Analysis of Data of A Statutory Health Insurance.
Scherbaum N; Holzbach R; Stammen G; Kirchof U; Bonnet U
Pharmacopsychiatry; 2020 Jan; 53(1):37-39. PubMed ID: 31132796
[TBL] [Abstract][Full Text] [Related]
22. Impact of policy changes and drug shortages on acamprosate and naltrexone use in Ontario, Canada.
Konstantelos N; Tourchian N; McCormack D; Lecce P; Tadrous M; Gomes T
Drug Alcohol Depend; 2023 Jan; 242():109705. PubMed ID: 36463765
[TBL] [Abstract][Full Text] [Related]
23. Medications for Alcohol and Opioid Use Disorders and Risk of Suicidal Behavior, Accidental Overdoses, and Crime.
Molero Y; Zetterqvist J; Binswanger IA; Hellner C; Larsson H; Fazel S
Am J Psychiatry; 2018 Oct; 175(10):970-978. PubMed ID: 30068260
[TBL] [Abstract][Full Text] [Related]
24. Patient Barriers and Facilitators to Medications for Opioid Use Disorder in Primary Care.
Tofighi B; Williams AR; Chemi C; Suhail-Sindhu S; Dickson V; Lee JD
Subst Use Misuse; 2019; 54(14):2409-2419. PubMed ID: 31429351
[No Abstract] [Full Text] [Related]
25. Integrating substance use care into primary care for adolescents and young adults: Lessons learned.
Bagley SM; Hadland SE; Schoenberger SF; Gai MJ; Topp D; Hallett E; Ashe E; Samet JH; Walley AY
J Subst Abuse Treat; 2021 Oct; 129():108376. PubMed ID: 34080547
[TBL] [Abstract][Full Text] [Related]
26. National outpatient medication utilization for opioid and alcohol use disorders from 2014 to 2016.
Evoy KE; Roccograndi L; Le S; Leonard CE; Covvey JR; Ochs L; Peckham AM; Soprano SE; Reveles KR
J Subst Abuse Treat; 2020 Dec; 119():108141. PubMed ID: 33138926
[TBL] [Abstract][Full Text] [Related]
27. Pharmacotherapy for alcohol use disorder among adults with medical disorders in Sweden.
Månsson A; Danielsson AK; Sjöqvist H; Glatz T; Lundin A; Wallhed Finn S
Addict Sci Clin Pract; 2024 May; 19(1):41. PubMed ID: 38764075
[TBL] [Abstract][Full Text] [Related]
28. Documented opioid use disorder and its treatment in primary care patients across six U.S. health systems.
Boudreau DM; Lapham G; Johnson EA; Bobb JF; Matthews AG; McCormack J; Liu D; Campbell CI; Rossom RC; Binswanger IA; Yarborough BJ; Arnsten JH; Cunningham CO; Glass JE; Murphy MT; Zare M; Hechter RC; Ahmedani B; Braciszewski JM; Horigian VE; Szapocznik J; Samet JH; Saxon AJ; Schwartz RP; Bradley KA
J Subst Abuse Treat; 2020 Mar; 112S():41-48. PubMed ID: 32220410
[TBL] [Abstract][Full Text] [Related]
29. Effect of Integrating Substance Use Disorder Treatment into Primary Care on Inpatient and Emergency Department Utilization.
Wakeman SE; Rigotti NA; Chang Y; Herman GE; Erwin A; Regan S; Metlay JP
J Gen Intern Med; 2019 Jun; 34(6):871-877. PubMed ID: 30632103
[TBL] [Abstract][Full Text] [Related]
30. Sharp decline in hospital and emergency department initiated buprenorphine for opioid use disorder during COVID-19 state of emergency in California.
Herring AA; Kalmin M; Speener M; Goodman-Meza D; Snyder H; Campbell A; Moulin A; Shoptaw S
J Subst Abuse Treat; 2021 Apr; 123():108260. PubMed ID: 33612194
[TBL] [Abstract][Full Text] [Related]
31. Pharmacotherapy for Substance Use Disorders.
Klein JW
Med Clin North Am; 2016 Jul; 100(4):891-910. PubMed ID: 27235620
[TBL] [Abstract][Full Text] [Related]
32. How Does Telehealth Expansion Change Access to Healthcare for Patients With Different Types of Substance Use Disorders?
Tilhou AS; Burns M; Chachlani P; Chen Y; Dague L
Subst Use Addctn J; 2024 Jul; 45(3):473-485. PubMed ID: 38494728
[TBL] [Abstract][Full Text] [Related]
33. Bridging Recovery Initiative Despite Gaps in Entry (BRIDGE): study protocol for a randomized controlled trial of a bridge clinic compared with usual care for patients with opioid use disorder.
Marcovitz DE; White KD; Sullivan W; Limper HM; Dear ML; Buie R; Edwards DA; Chastain C; Kast KA; Lindsell CJ;
Trials; 2021 Oct; 22(1):757. PubMed ID: 34717736
[TBL] [Abstract][Full Text] [Related]
34. Mortality of treatment-seeking men and women with alcohol, opioid or other substance use disorders - A register-based follow-up study.
Pitkänen T; Kaskela T; Levola J
Addict Behav; 2020 Jun; 105():106330. PubMed ID: 32088539
[TBL] [Abstract][Full Text] [Related]
35. Medical complications associated with substance use disorders in patients with type 2 diabetes and hypertension: electronic health record findings.
Winhusen T; Theobald J; Kaelber DC; Lewis D
Addiction; 2019 Aug; 114(8):1462-1470. PubMed ID: 30851217
[TBL] [Abstract][Full Text] [Related]
36. Using medication-assisted treatment for substance use disorders: evidence of barriers and facilitators of implementation.
Roman PM; Abraham AJ; Knudsen HK
Addict Behav; 2011 Jun; 36(6):584-589. PubMed ID: 21377275
[TBL] [Abstract][Full Text] [Related]
37. Medication prescribing for alcohol use disorders during alcohol-related encounters in a Colorado regional healthcare system.
Chockalingam L; Burnham EL; Jolley SE
Alcohol Clin Exp Res; 2022 Jun; 46(6):1094-1102. PubMed ID: 35723682
[TBL] [Abstract][Full Text] [Related]
38. Medication-assisted treatment for opioid use disorder within a 12-step based treatment center: Feasibility and initial results.
Klein AA; Seppala MD
J Subst Abuse Treat; 2019 Sep; 104():51-63. PubMed ID: 31370985
[TBL] [Abstract][Full Text] [Related]
39. Alcohol Medical Intervention Clinic: A Rapid Access Addiction Medicine Model Reduces Emergency Department Visits.
Corace K; Willows M; Schubert N; Overington L; Mattingly S; Clark E; Leduc N; Hutton B; Hebert G
J Addict Med; 2020; 14(2):163-171. PubMed ID: 31403977
[TBL] [Abstract][Full Text] [Related]
40. Randomized trial of onsite versus referral primary medical care for veterans in addictions treatment.
Saxon AJ; Malte CA; Sloan KL; Baer JS; Calsyn DA; Nichol P; Chapko MK; Kivlahan DR
Med Care; 2006 Apr; 44(4):334-42. PubMed ID: 16565634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
